ArticleFarmaceuticos comunitarios2023
[Assessing risk factors for cognitive impairment in rural areas: methodology and pilot study in community pharmacy].
Article in Farmaceuticos comunitarios, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Developing a Patient Profile for the Detection of Cognitive Decline in Subjective Memory Complaint Patients: A Scoping Review and Cross-Sectional Study in Community Pharmacy.Healthcare (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cognitive impairment is known to be mediated by a variety of risk factors, with age being the most influential of these. The worldwide phenomenon of an aging population makes decoupling old age from disease through the concept of healthy aging a matter of major interest. In Spain, rural depopulated areas, where the lack of health services is an additional concern, constitute a group of particularly aged population. Community pharmacies are widely distributed throughout the territory and are in close contact with this vulnerable population group. Methodology: We designed and piloted a methodology to assess cognitive impairment and healthy aging from a holistic point of view. Our questionnaire comprises five sections: cognitive impairment, sociodemographic factors, health problems, lifestyle and psychosocial factors. >Results: The estimated prevalences of cognitive impairment and healthy aging in our cohort were 28.2 % and 15.4 %, respectively. The prevalences (or the population mean values) found for well-known risk and protective factors for cognitive impairment were consistent with those described for Spanish population in the scientific literature. The results showed that our questionnaire can be an appropriate tool for collecting information in our media and suitable for researching how modifiable risk and protective factors influence cognitive status from a holistic perspective. Conclusion: The complex interrelationships between variables should be further investigated. In this respect, novel areas, such as psychosocial variables, should also be the focus of efforts to advance the cognitive impairment knowledge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.